AIS
RETA

AM Investment Strategies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

AM Investment Strategies’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,465
Closed -$1.25M – 122
2021
Q3 		$1.25M Hold
12,465
– – 0.33% 41
2021
Q2 		$1.76M Hold
12,465
– – 0.45% 34
2021
Q1 		$1.24M Buy
12,465
+4,100
+49% +$478K 0.35% 38
2020
Q4 		$1.13M Sell
8,365
-3,760
-31% -$494K 0.35% 37
2020
Q3 		$1.18M Buy
+12,125
New +$1.51M 0.41% 34

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AM Investment Strategies's RETA Position: Q4 2021 in Review

AM Investment Strategies sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2021, closing a stake of 12,465 shares — an estimated $1.25M sold.

AM Investment Strategies first reported a position in RETA in Q3 2020 and held it in 5 quarters. The position peaked at $1.76M in Q2 2021. 151 funds tracked by Wall St. Rank hold RETA as of Q4 2021.

  • AM Investment Strategies reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • AM Investment Strategies sold 12,465 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2021, an estimated $1.25M.
  • AM Investment Strategies first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2020 and held it in 5 quarters.
  • AM Investment Strategies's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.76M in Q2 2021.
  • 151 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2021.

Based on AM Investment Strategies's 13F filing for Q4 2021, filed 2 Feb 2022.